1 / 44
Featured in this issue:
Volume 15 Number 1
A Lupin Group Company
CUSTOMER CARE LINE
0860 PHARMA (742 762) / +27 21 707 7000
www.pharmadynamics.co.zathe
endurance
ACE-inhibitor
PEARINDA 4, 8.
Each tablet contains 4, 8 mg perindopril
tert
-butylamine respectively. S3 A41/7.1.3/0649, 0650. NAM NS2 10/7.1.3/0476, 0477. For
full prescribing information, refer to the professional information approved by SAHPRA, April 2009.
PEARINDA PLUS 4.
Each tablet contains 4 mg
perindopril
tert
-butylamine and 1,25 mg indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing information, refer to the
professional information approved by SAHPRA, April 2010.
1)
The EUROPA study Investigators. “Efficacy of perindopril in reduction of cardiovascular
events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)”. The
Lancet 2003;362:782-788.
2)
The PREAMI study Investigators. “Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular
remodelling and clinical outcome. Results of the randomized perindopril and remodelling in elderly with acute myocardial infarction (PREAMI) study”. Arch
Intern Med 2006;166:659-666.
3)
PROGRESS Collaborative Group. “Randomised trial of a perindopril-based blood-pressure-lowering regimen among
6105 individuals with previous stroke or transient ischaemic attack”. The Lancet 2001;358:1033-41.
4)
Guerin AP,
et al.
“Impact of Aortic Stiffness
Attenuation on Survival of Patients in End-Stage Renal Failure”. Circulation 2001;103;987-992.
PAH515/06/2018.
Perindopril has proven outcomes in:
đŏ +.+* .5ŏ .0!.5ŏ %/! /!
1
đŏ 10!ŏ 5+ . % (ŏ *" . 0%+*
2
đŏ 0.+'!
3
đŏ * ġ/0 #!ŏ !* (ŏ %(1.!
4
!! ŏ
endurance
3$!*ŏ0.! 0%*#ŏ
ŏ %/! /!ĕ
July 2018
SAJDVD
The South African Journal of Diabetes & Vascular Disease
The electronic version of
the journal is available at
www.diabetesjournal.co.zaProfile, bacteriology and
antibiotic susceptibility of
diabetic foot ulcers
Risk assessment in adults
with type 2 diabetes or
metabolic syndrome
Treatment of hypertension,
diabetes and
hypercholesterolaemia
Left atrial function in
patients with type 2 diabetes
mellitus
Risk factors for diabetic foot
ulceration
2017 SEMDSA diabetes
management guidelines
Reviews
Research Articles
Patient Leaflets
Drug Trends
News